Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 3
A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma
This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, …
Ganglioneuroblastoma, NodularNeuroblastoma
National Cancer Institute (NCI)NCT06172296
Phase 3
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
This phase III trial studies iobenguane I-131 or lorlatinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or g…
GanglioneuroblastomaGanglioneuroblastoma, NodularNeuroblastoma
Children's Oncology GroupNCT03126916